Earlier this week, the Office of Inspector General OIG issued a Special Fraud Alert (Alert) on speaker programs by pharmaceutical and medical device companies in connection with the Federal Anti-Kickback Statute. In the...more
11/23/2020
/ Anti-Kickback Statute ,
FDA Approval ,
Food and Drug Administration (FDA) ,
Fraud ,
Health Care Providers ,
Marketing ,
Medical Devices ,
OIG ,
Pharmaceutical Industry ,
Remuneration ,
Speaker Programs